Vertex Pharmaceuticals Incorporated vs BNP Paribas SA
Comparaison de la capitalisation boursière au fil du temps
Vertex Pharmaceuticals Incorporated
$130.6B
Rang #131
BNP Paribas SA
$131.6B
Rang #128
Capitalisation boursière au fil du temps
Moments clés
- Vertex Pharmaceuticals Incorporated a dépassé BNP Paribas SA avant 1996
- BNP Paribas SA a dépassé Vertex Pharmaceuticals Incorporated avant 1997
- Vertex Pharmaceuticals Incorporated a dépassé BNP Paribas SA avant 2000
- BNP Paribas SA a dépassé Vertex Pharmaceuticals Incorporated avant 2001
- Vertex Pharmaceuticals Incorporated a dépassé BNP Paribas SA avant 2018
- BNP Paribas SA a dépassé Vertex Pharmaceuticals Incorporated avant 2026
Comparaison année par année
| Année | Vertex Pharmaceuticals Incorporated | BNP Paribas SA | Leader |
|---|---|---|---|
| 2026 | $130.6B | $131.6B | BNP Paribas SA |
| 2025 | $115.1B | $93.2B | Vertex Pharmaceuticals Incorporated |
| 2024 | $102.2B | $62.1B | Vertex Pharmaceuticals Incorporated |
| 2023 | $103.3B | $61.5B | Vertex Pharmaceuticals Incorporated |
| 2022 | $73.3B | $48.9B | Vertex Pharmaceuticals Incorporated |
| 2021 | $55.7B | $52.0B | Vertex Pharmaceuticals Incorporated |
| 2020 | $60.0B | $35.2B | Vertex Pharmaceuticals Incorporated |
| 2019 | $55.6B | $43.1B | Vertex Pharmaceuticals Incorporated |
| 2018 | $42.1B | $30.0B | Vertex Pharmaceuticals Incorporated |
| 2017 | $38.0B | $44.8B | BNP Paribas SA |
| 2016 | $18.7B | $41.8B | BNP Paribas SA |
| 2015 | $31.9B | $34.4B | BNP Paribas SA |
| 2014 | $30.2B | $31.6B | BNP Paribas SA |
| 2013 | $18.9B | $35.3B | BNP Paribas SA |
| 2012 | $10.6B | $25.7B | BNP Paribas SA |
| 2011 | $8.4B | $17.4B | BNP Paribas SA |
| 2010 | $8.9B | $26.3B | BNP Paribas SA |
| 2009 | $10.9B | $30.0B | BNP Paribas SA |
| 2008 | $7.7B | $15.9B | BNP Paribas SA |
| 2007 | $5.9B | $37.0B | BNP Paribas SA |
| 2006 | $9.5B | $39.4B | BNP Paribas SA |
| 2005 | $7.0B | $30.0B | BNP Paribas SA |
| 2004 | $2.7B | $21.7B | BNP Paribas SA |
| 2003 | $2.6B | $19.5B | BNP Paribas SA |
| 2002 | $4.0B | $14.2B | BNP Paribas SA |
| 2001 | $6.2B | $17.6B | BNP Paribas SA |
| 2000 | $18.1B | $16.0B | Vertex Pharmaceuticals Incorporated |
| 1999 | $4.4B | $15.4B | BNP Paribas SA |
| 1998 | $3.8B | $11.6B | BNP Paribas SA |
| 1997 | $4.2B | $7.3B | BNP Paribas SA |
| 1996 | $5.1B | $3.9B | Vertex Pharmaceuticals Incorporated |
| 1995 | $3.4B | $3.8B | BNP Paribas SA |
| 1994 | $1.9B | $3.8B | BNP Paribas SA |